# Attovia Therapeutics Inc. (ATTO) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Industrials / Professional Services. Price $25.55, market value $1.2 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Attovia Therapeutics Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 864.0×**. Each dollar of revenue is priced at 864.0×, a level that requires very high margins or very fast growth to justify.
- **Free-cash-flow yield: -5.3%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: 56.4%**. A 56.4% return on equity is extremely high; check whether buybacks or debt have shrunk the equity base, which flatters the ratio.
- **Return on invested capital: 20.9%**. Return on all capital, debt included, is 20.9%: comfortably above what that capital costs.
- **Return on assets: -36.5%**. Each dollar of assets produces -36.5% of profit.

## Growth
- **EPS growth (1 yr): -35.1%**. Earnings per share fell 35.1%.

## Financial health
- **Net debt / EBITDA: 2.2×**. It would take 2.2 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 14.20** (quick 14.20). Current assets cover the next year's liabilities 14.20 times.
- **Altman Z-score: 1.38**. A Z-score of 1.38 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Attovia Therapeutics Inc. does not currently pay a dividend, but it returned -0.0% of its market value through buybacks over the last year.

## Analyst view
- **Analyst consensus: strong_buy** (5 analysts). 5 analysts cover Attovia Therapeutics Inc.; the consensus is strong_buy, with an average price target of $42.20 (+65% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **From 52-week high: -7.6%** (58.2% above the low). Trading 8% below its 52-week high.
- **RSI (14-day): 63**. An RSI of 63 is neutral.

Live score and charts: https://foliofundamentals.com/analyzer?s=ATTO · Page: https://foliofundamentals.com/stocks/atto

Not investment advice.